Skip to content Skip to menu

New era for PBS but Australians’ access to medicines not yet assured

Friday, 1 August 2008

Media Release

Medicines Australia has urged the Federal Government to continue with PBS reform to ensure that initiatives to improve access to new medicines for Australian patients are quickly implemented.

“A new era of the PBS starts today with major price reductions of up to 25 per cent for many older medicines on the PBS,” Ian Chalmers, Medicines Australia Chief Executive said today.

“But the challenge for PBS reform is to ensure that savings from these price reductions – at least $3 billion over ten years – are used to ensure Australians have access to new medicines in the future.

“PBS reform was always about using a more competitive generics market to guarantee that Australians will have access in the future to cutting edge therapies.

“PBS price cuts for older medicines commenced today. But the job is only half done because it’s not yet clear that Australians’ access to new medicines in the future is assured.

“Medicines Australia is working with the Federal Government through the Access to Medicines Working Group. It is hoped this collaboration will ensure future access to innovative new medicines for Australian patients.”

From today the price the Government pays for a range of generic and patent-expired originator medicines on the PBS will automatically fall by up to 25 per cent.

–ENDS–

Contact Person:

Jamie Nicholson
Media Communications Manager
Phone: 0419 220 293
Email:
Jamie.Nicholson@medicinesaustralia.com.au

Information

As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at medicinesaustralia.com.au/covid-19/

Top